Baldwin Brothers LLC Gilead Sciences, Inc. Transaction History

Baldwin Brothers LLC

$1.43 Billion
Q3 2024

A detailed history of Baldwin Brothers LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Baldwin Brothers LLC holds 304 shares of GILD stock, worth $28,092. This represents 0.0% of its overall portfolio holdings.

Number of Shares

304

Previous 271 12.18%

Holding current value

$28,092

Previous $18,000 38.89%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$66.59 - $83.99 $2,197 - $2,771	33 Added 12.18%	304 $25,000
Q2 2024 Jul 12, 2024	SELL	$63.15 - $72.88 $410,727 - $474,011	-6,504 Reduced 96.0%	271 $18,000
Q1 2024 Apr 12, 2024	SELL	$71.58 - $87.29 $634,771 - $774,087	-8,868 Reduced 56.69%	6,775 $496,000
Q4 2023 Jan 08, 2024	SELL	$73.27 - $83.09 $1.21 Million - $1.37 Million	-16,507 Reduced 51.34%	15,643 $1.27 Million
Q3 2023 Oct 10, 2023	SELL	$73.94 - $80.67 $66,176 - $72,199	-895 Reduced 2.71%	32,150 $2.41 Million
Q2 2023 Jul 14, 2023	SELL	$76.01 - $86.7 $155,212 - $177,041	-2,042 Reduced 5.82%	33,045 $2.55 Million
Q1 2023 Apr 21, 2023	SELL	$77.31 - $88.08 $24,584 - $28,009	-318 Reduced 0.9%	35,087 $2.91 Million
Q4 2022 Jan 27, 2023	BUY	$62.32 - $89.47 $2.19 Million - $3.15 Million	35,162 Added 14469.96%	35,405 $0
Q2 2022 Jul 18, 2022	SELL	$57.72 - $65.01 $865 - $975	-15 Reduced 5.81%	243 $15,000
Q1 2022 Apr 13, 2022	BUY	$57.92 - $72.58 $405 - $508	7 Added 2.79%	258 $15,000
Q1 2021 Apr 08, 2021	SELL	$60.0 - $68.46 $6,000 - $6,845	-100 Reduced 28.49%	251 $16,000
Q1 2020 Apr 15, 2020	BUY	$62.63 - $80.22 $8,517 - $10,909	136 Added 63.26%	351 $26,000
Q4 2019 Jan 29, 2020	SELL	$61.62 - $67.78 $8,811 - $9,692	-143 Reduced 39.94%	215 $14,000
Q3 2019 Oct 10, 2019	SELL	$62.51 - $69.0 $4,375 - $4,830	-70 Reduced 16.36%	358 $23,000
Q2 2019 Jul 19, 2019	SELL	$61.87 - $69.38 $1,237 - $1,387	-20 Reduced 4.46%	428 $29,000
Q1 2019 Apr 24, 2019	SELL	$62.53 - $70.05 $22,510 - $25,218	-360 Reduced 44.55%	448 $29,000
Q4 2018 Feb 01, 2019	BUY	$60.54 - $79.0 $15,679 - $20,461	259 Added 47.18%	808 $51,000
Q3 2018 Oct 26, 2018	SELL	$71.28 - $78.92 $4,989 - $5,524	-70 Reduced 11.31%	549 $42,000
Q2 2018 Jul 24, 2018	BUY	$64.88 - $75.68 $6,488 - $7,568	100 Added 19.27%	619 $44,000
Q1 2018 Apr 16, 2018	BUY	$72.84 - $88.8 $8,813 - $10,744	121 Added 30.4%	519 $39,000
Q4 2017 Jan 24, 2018	BUY	$71.15 - $83.52 $8,395 - $9,855	118 Added 42.14%	398 $29,000
Q3 2017 Oct 26, 2017	BUY	$72.11 - $85.47 $20,190 - $23,931	280	280 $23,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.

Account

Baldwin Brothers LLC Gilead Sciences, Inc. Transaction History